Excess Economic Burden of Comorbidities in COPD: a 15-year population-based study (COPD comorbidity costs)

Study identification

• EU PAS number:
  EUPAS18242
• Study ID:
  18243
• Official title and acronym:
  Excess Economic Burden of Comorbidities in COPD: a 15-year population-based study (COPD comorbidity costs)
• DARWIN EU® study:
  No
• Study countries:
  Canada
• Study description:
  This study utilized 16-year of health administrative data in British Columbia, Canada, to investigate the excess direct medical costs of COPD patients, over and beyond the costs incurred by the general non-COPD population, as well as the proportion and distribution of comorbidity-attributable medical costs in such excess economic burden.
• Study status:
  Finalised

Research institutions and networks

Institutions

Not applicable - administrative data-analysis

Study timelines

Date when funding contract was signed

Actual:04/03/2014

Study start date

Actual:04/10/2016

Data analysis start date

Actual:08/11/2016

Date of final study report

Actual:03/01/2017

Sources of funding

Other

More details on funding

Genome Canada, Canadian Respiratory Research Network

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable